|
1
|
Kostler WJ, Hejna M, Wenzel C and
Zielinski CC: Oral mucositis complicating chemotherapy and/or
radiotherapy: Options for prevention and treatment. CA Cancer J
Clin. 51:290–315. 2001.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sonis ST: Mucositis as a biological
process: A new hypothesis for the development of
chemotherapy-induced stomatotoxicity. Oral Oncol. 34:39–43.
1998.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sonis ST: New thoughts on the initiation
of mucositis. Oral Dis. 16:597–600. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sonis ST: The pathobiology of mucositis.
Nat Rev Cancer. 4:277–284. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Sonis ST and Costello KA: A database for
mucositis induced by cancer chemotherapy. Eur J Cancer B Oral
Oncol. 31B:258–260. 1995.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Stone R, Fliedner MC and Smiet AC:
Management of oral mucositis in patients with cancer. Eur J Oncol
Nurs. 9 (Suppl 1):S24–S32. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Trotti A, Bellm LA, Epstein JB, Frame D,
Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L and Zilberberg MD:
Mucositis incidence, severity and associated outcomes in patients
with head and neck cancer receiving radiotherapy with or without
chemotherapy: A systematic literature review. Radiother Oncol.
66:253–262. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Trucci VM, Veeck EB and Morosolli ARC:
Current strategies for the management of oral mucositis induced by
radiotherapy or chemotherapy. Rev Odonto Cienc. 24:309–314.
2009.
|
|
9
|
Lalla RV, Sonis ST and Peterson DE:
Management of oral mucositis in patients who have cancer. Dent Clin
North Am. 52:61–77. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Peterson DE: New strategies for management
of oral mucositis in cancer patients. J Support Oncol. 4 (Suppl
1):S9–S13. 2006.PubMed/NCBI
|
|
11
|
Yeoh AS, Gibson RJ, Yeoh EE, Bowen JM,
Stringer AM, Giam KA and Keefe DM: A novel animal model to
investigate fractionated radiotherapy-induced alimentary mucositis:
The role of apoptosis, p53, nuclear factor-kappaB, COX-1, and
COX-2. Mol Cancer Ther. 6:2319–2327. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Parkin J and Cohen B: An overview of the
immune system. Lancet. 357:1777–1789. 2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Goldman L and Ausiello D (eds): Principles
of cancer treatment. In: Internal Medicine Treaty. Campus Elsevier,
Rio de Janeiro, 2005.
|
|
14
|
Kolios G, Petoumenos C and Nakos A:
Mediators of inflammation: Production and implication in
inflammatory bowel disease. Hepatogastroenterology. 45:1601–1609.
1998.PubMed/NCBI
|
|
15
|
Mitchell R, Kumar V, Abbas A and Fausto N:
Robbins and Cotran Pathologic Basis of Diseases. 7th edition.
Elsevier, Rio de Janeiro, 2006.
|
|
16
|
Aarestrup B: In situ evaluation of
mediators of the inflammatory response and apoptosis process in
chronic periodontitis in patients with AIDS. Niteroi, Universidade
Federal Fluminense, 2006.
|
|
17
|
Baliga RS, Chaves AA, Jing L, Ayers LW and
Bauer JA: AIDS-related vasculopathy: Evidence for oxidative and
inflammatory pathways in murine and human AIDS. Am J Physiol Heart
Circ Physiol. 289:H1373–H1380. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Duda A, Stange A, Lüftenegger D, Stanke N,
Westphal D, Pietschmann T, Eastman SW, Linial ML, Rethwilm A and
Lindemann D: Prototype foamy virus envelope glycoprotein leader
peptide processing is mediated by a Furin-like cellular protease,
but cleavage is not essential for viral infectivity. J Virol.
78:13865–13870. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Consolaro A: Cellular stress: Precedes and
is present in inflammation. In: Inflammation and Repair. Dental
Press, Maringá, 2009.
|
|
20
|
Azevedo IM, Kumakura HS, Alloufa SL,
Mourão TS, Souza PM, Carvalho MDF, Medeiros VB, Araújo-Filho I,
Rêgo ACM and Medeiros AC: Effect of simvastatin in attenuation of
mucositis induced by methotrexate in rats. J Surg Clin Res.
1:22–32. 2010.
|
|
21
|
Flores D and Lisart R: Effectiveness of
palifermin in the prevention of oral mucositis in patients with
haematological cancers. Farm Hosp. 34:163–169. 2010.PubMed/NCBI View Article : Google Scholar : (In Spanish).
|
|
22
|
Spielberger R, Stiff P, Bensinger W,
Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K,
Noga S, et al: Palifermin for oral mucositis after intensive
therapy for hematologic cancers. N Engl J Med. 351:2590–2598.
2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Schmidt-Choudhury A, Furuta GT, Lavigne
JA, Galli SJ and Wershil BK: The regulation of tumor necrosis
factor-alpha production in murine mast cells: Pentoxifylline or
dexamethasone inhibits IgE-dependent production of TNF-alpha by
distinct mechanisms. Cell Immunol. 171:140–1446. 1996.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Raber-Durlacher JE, von Bültzingslöwen I,
Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG,
Pettersson BG, Soga Y, et al: Systematic review of cytokines and
growth factors for the management of oral mucositis in cancer
patients. Support Care Cancer. 21:343–355. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Campos MI, Vieira WD, Campos CN, Aarestrup
FM and Aarestrup BJ: Atorvastatin and trans-caryophyllene for the
prevention of leukopenia in an experimental chemotherapy model in
Wistar rats. Mol Clin Oncol. 3:825–828. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Basile AC, Sertie JA, Freitas PC and
Zanini AC: Anti-inflammatory activity of oleoresin from Brazilian
Copaifera. J Ethnopharmacol. 22:101–109. 1988.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pereira FJ, Martins FT, Corrêa RS, Moreira
ME, Costa A, Santos MH, Polo M and Barbosa LC: Isolation, chemical
composition and anti-inflammatory activity of Copaifera
langsdorffii Desf. fruit peels essential oil according to
successive hydrodistillations. Acta Farm Bonaer. 27:369–374.
2008.
|
|
28
|
Vilanova CM, Ribeiro SM, Machado RC,
Vieira SM, Lima SG, Nunes PH and Martins MC: Evaluation of
oil-resin activity of Copaifera sp. On gastric emptying in
Rattus novergicus. Emir J Food Agricult. 25:394–397.
2013.
|
|
29
|
Siddiqui MA and Wellington K: Palifermin:
In myelotoxic therapy-induced oral mucositis. Drugs. 65:2139–2149.
2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sonis ST: Efficacy of palifermin
(keratinocyte growth factor-1) in the amelioration of oral
mucositis. Core Evid. 4:199–205. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Fernandes ES, Passos GF, Medeiros R, da
Cunha FM, Ferreira J, Campos MM, Pianowski LF and Calixto JB:
Anti-inflammatory effects of compounds alpha-humulene and
(-)-trans-caryophyllene isolated from the essential oil of Cordia
verbenacea. Eur J Pharmacol. 569:228–236. 2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Leandro LM, Vargas Fde S, Barbosa PC,
Neves JK, da Silva JA and da Veiga-Junior VF: Chemistry and
biological activities of terpenoids from copaiba (Copaifera
spp.) oleoresins. Molecules. 17:3866–3889. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Paiva LA, de Alencar Cunha KM, Santos FA,
Gramosa NV, Silveira ER and Rao VS: Investigation on the wound
healing activity of oleo-resin from Copaifera langsdorffi in
rats. Phytother Res. 16:737–739. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Ward A and Clissold SP: Pentoxifylline. A
review of its pharmacodynamic and pharmacokinetic properties, and
its therapeutic efficacy. Drugs. 34:50–97. 1987.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sonis ST, Tracey C, Shklar G, Jenson J and
Florine D: An animal model for mucositis induced by cancer
chemotherapy. Oral Surg Oral Med Oral Pathol. 69:437–443.
1990.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Scully C, Epstein J and Sonis S: Oral
mucositis: A challenging complication of radiotherapy,
chemotherapy, and radiochemotherapy: Part 1, pathogenesis and
prophylaxis of mucositis. Head Neck. 25:1057–1070. 2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cai Y, Wang Z, Li J, Li N, Wei F and Liu
Q: Evaluation of an indirect ELISA using recombinant granule
antigen Gra7 for serodiagnosis of Toxoplasma gondii infection in
cats. J Parasitol. 101:37–40. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Grisham MB, Jourd'Heuil D and Wink DA:
Nitric oxide. I. Physiological chemistry of nitric oxide and its
metabolites: Implications in inflammation. Am J Physiol.
276:G315–G321. 1999.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fekrazad R and Chiniforush N: Oral
mucositis prevention and management by therapeutic laser in head
and neck cancers. J Lasers Med Sci. 5:1–7. 2014.PubMed/NCBI
|
|
40
|
Herrstedt J: Prevention and management of
mucositis in patients with cancer. Int J Antimicrob Agents.
16:161–163. 2000.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lara RN, da Guerra EN and de Melo NS:
Macroscopic and microscopic effects of GaAIAs diode laser and
dexamethasone therapies on oral mucositis induced by fluorouracil
in rats. Oral Health Prev Dent. 5:63–71. 2007.PubMed/NCBI
|
|
42
|
Pico JL, Avila-Garavito A and Naccache P:
Mucositis: Its occurrence, consequences, and treatment in the
oncology setting. Oncologist. 3:446–451. 1998.PubMed/NCBI
|
|
43
|
Silverman S Jr: Diagnosis and management
of oral mucositis. J Support Oncol. 5:13–21. 2007.PubMed/NCBI
|
|
44
|
Wardill HR, Bowen JM and Gibson RJ: New
pharmacotherapy options for chemotherapy-induced alimentary
mucositis. Expert Opin Biol Ther. 14:347–354. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Vanderhoof JA, Park JH, Mohammadpour H and
Blackwood D: Effects of dietary lipids on recovery from mucosal
injury. Gastroenterology. 98:1226–1231. 1990.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lima V, Vidal FD, Rocha FA, Brito GA and
Ribeiro RA: Effects of tumor necrosis factor-alpha inhibitors
pentoxifylline and thalidomide on alveolar bone loss in short-term
experimental periodontal disease in rats. J Periodontol.
75:162–168. 2004.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Jain P, Keservani R and Dahima R: In-vivo
characterization of hydrogel for treatment of chemo-radiotherapy
induced oral mucositis. Pharmacol Online. 1:1016–1025. 2010.
|
|
48
|
Allen R, Rapecki S and Higgs G: The role
of IL-10 in the inhibition of LPS-mediated TNF release from human
PBMCs by phosphodiesterase 4 (PDE4) inhibitors. Inflamm Res.
46(218)1997.
|
|
49
|
Dias DS, Fontes LB, Crotti AE, Aarestrup
BJ, Aarestrup FM, da Silva Filho AA and Corrêa JO: Copaiba oil
suppresses inflammatory cytokines in splenocytes of C57Bl/6 mice
induced with experimental autoimmune encephalomyelitis (EAE).
Molecules. 19:12814–12826. 2014.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Guo K, Mou X, Huang J, Xiong N and Li H:
Trans-caryophyllene suppresses hypoxia-induced neuroinflammatory
responses by inhibiting NF-κB activation in microglia. J Mol
Neurosci. 54:41–48. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Veiga Junior VF, Rosas EC, Carvalho MV,
Henriques MG and Pinto AC: Chemical composition and
anti-inflammatory activity of copaiba oils from Copaifera
cearensis Huber ex Ducke, Copaifera reticulata Ducke and
Copaifera multijuga Hayne-a comparative study. J
Ethnopharmacol. 112:248–254. 2007.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wright TH, Yazbeck R, Lymn KA, Whitford
EJ, Cheah KY, Butler RN, Feinle-Bisset C, Pilichiewicz AN, Mashtoub
S and Howarth GS: The herbal extract, Iberogast, improves jejunal
integrity in rats with 5-fluorouracil (5-FU)-induced mucositis.
Cancer Biol Ther. 8:923–929. 2009.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Cheah KY, Howarth GS and Bastian SE: Grape
seed extract dose-responsively decreases disease severity in a rat
model of mucositis; concomitantly enhancing chemotherapeutic
effectiveness in colon cancer cells. PLoS One.
9(e85184)2014.PubMed/NCBI View Article : Google Scholar
|
